What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001409751
Total reported value
$1.2B
$1.2B
14 檔
56.4%
During the Q3 2024 filing period, Coliseum Capital Management, LLC (CIK: 0001409751) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $1.2B across 14 reported positions.
In Q3 2024, Coliseum Capital Management, LLC adopted a defensive or profit-taking posture, trimming 5 positions and completely liquidating 2 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GIL | Gildan Activewear Inc | Stock-Consumer Disc | 27.13% | — | -41.37% | |
| 2 | UTI | Universal Technical Institut | Stock-Other | 14.68% | -8.18% | — | |
| 3 | SONO | Sonos Inc | Stock-Other | 8.49% | +1.19% | +52.69% | |
| 4 | GMS1EUR | Gms Inc | Stock-Other | 7.04% | — | -14.88% | |
| 5 | HRI | Herc Holdings Inc | Stock-Other | 6.05% | +0.22% | — | |
| 6 | MCFT | Mastercraft Boat Holdings In | Stock-Other | 5.94% | +1.99% | — | |
| 7 | ACH | Accendra Health Inc | Stock-Other | 5.53% | +1.41% | — | |
| 8 | WSC | Willscot Holdings CORP | Stock-Industrials | 5.01% | +1.95% | +179.13% | |
| 9 | RCM1USD | R1 Rcm Inc | Stock-Other | 4.80% | — | -65.92% | |
| 10 | PRPL | Purple Innovation Inc | Stock-Other | 4.48% | -1.10% | — | |
| 11 | MODVQ | Modivcare Inc | Stock-Other | 4.12% | — | — | |
| 12 | FTRE | Fortrea Holdings Inc | Stock-Healthcare | 3.50% | — | -6.83% | |
| 13 | INNV | Innovage Holding CORP | Stock-Other | 2.29% | -0.73% | EXIT | |
| 14 | ✓ | Lazydays Holdings Inc | Stock-Other | 0.95% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | HRI | Herc Holdings Inc | +6.1% | NEW | New buy |
| 2 | ACH | Accendra Health Inc | +5.5% | NEW | New buy |
| 3 | WSC | Willscot Holdings CORP | +3.4% | +179.13% | Add |
| 4 | SONO | Sonos Inc | +2.3% | +52.69% | Add |
| 5 | UTI | Universal Technical Institut | +1.6% | — | Unchanged |
| 6 | INNV | Innovage Holding CORP | +0.3% | -11.80% | Trim |
| 7 | MCFT | Mastercraft Boat Holdings In | +0.3% | — | Unchanged |
| 8 | GMS1EUR | Gms Inc | +0.3% | -14.88% | Trim |
| 9 | PRPL | Purple Innovation Inc | +0.1% | — | Unchanged |
| 10 | FTRE | Fortrea Holdings Inc | -0.5% | -6.83% | Trim |
| 11 | ✓ | Lazydays Holdings Inc | -0.5% | — | Unchanged |
| 12 | USFD | US Foods Holding CORP | -0.9% | EXIT | Sold out |
| 13 | PPHMEUR | Avid Bioservices Inc | -1.1% | EXIT | Sold out |
| 14 | MODVQ | Modivcare Inc | -2.9% | — | Unchanged |
| 15 | RCM1USD | R1 Rcm Inc | -6.7% | -65.92% | Trim |
| 16 | GIL | Gildan Activewear Inc | -7.2% | -41.37% | Trim |
According to official SEC Form 13F filings, Coliseum Capital Management, LLC reported a total U.S. public equity portfolio value of $1.2B across 14 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GIL, UTI, SONO) accounted for 56.4% of total reported equity market value during Q3 2024.
Top New Position Initiated
HRI
市值: $62.5M
Top Position Liquidated / Trimmed
PPHMEUR
前期市值: $12.5M
During Q3 2024, Coliseum Capital Management, LLC's top holdings by market value included GIL (27.1%)、UTI (14.7%)、SONO (8.5%). The largest single position, GIL, represented 27.1% of total portfolio value.
In Q3 2024, Coliseum Capital Management, LLC made 11 total portfolio adjustments, initiating 2 new buys, adding to 2 positions, trimming 5 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.